PRLD logo

Prolight Diagnostics Stock Price

Symbol: NGM:PRLDMarket Cap: SEK 192.4mCategory: Healthcare

PRLD Share Price Performance

PRLD Community Fair Values

    Recent PRLD News & Updates

    No updates

    Prolight Diagnostics AB (publ) Key Details

    SEK 37.4m

    Revenue

    SEK 0

    Cost of Revenue

    SEK 37.4m

    Gross Profit

    SEK 66.3m

    Other Expenses

    -SEK 28.9m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.041
    Gross Margin
    100.00%
    Net Profit Margin
    -77.39%
    Debt/Equity Ratio
    0%

    Prolight Diagnostics AB (publ) Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About PRLD

    Founded
    1999
    Employees
    16
    CEO
    Ulf Bladin
    WebsiteView website
    prolightdx.com

    Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing in Sweden. It engages in the development of PLD micro flex and flex membrane. Prolight Diagnostics AB (publ) was incorporated in 1999 and is based in Stockholm, Sweden.

    Swedish Market Performance

    • 7 Days: -1.6%
    • 3 Months: 2.8%
    • 1 Year: -1.9%
    • Year to Date: 0.06%
    Over the last 7 days, the market has dropped 1.6%, driven by a pullback of 1.4% in the Industrials sector. Overall the market has been flat in the last year. As for the next few years, earnings are expected to grow by 17% per annum. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading